PTED Versus Radiofrequency Ablation for Lumbar Disc Herniation
PTED
Efficacy and Safety of Percutaneous Transforaminal Endoscopic Discectomy Versus Radiofrequency Ablation in the Treatment of Lumbar Intervertebral Disc Herniation: a Case-control Study
2 other identifiers
interventional
100
1 country
1
Brief Summary
Lumbar disc herniation (LDH) is a common and frequently-occurring disease giving rise to low back pain and (or) leg pain. There are about 1.5 million people with LDH-related pain, accounting for 10% of outpatients each year in China. The mechanism of LDH-related pain is that the degeneration causes the protrusion of the intervertebral disc directly to the lower lumbar nerve root or spinal cord, and the chemical stimulation plays a key role in it. Currently, LDH treatments are mainly divided into conservative treatment, surgical treatment and minimally invasive treatment. The minimally invasive technique is a new technology that has been arising in recent years, with small wound, little bleeding and quick recovery. It mainly includes collagenase dissolving, laser decompression, radiofrequency ablation, etc. Intervertebral disc radiofrequency ablation is an early application of minimally invasive technique with a wide range of applications in a long time. The percutaneous transforaminal endoscopic discectomy (PTED) is a new technique, which is applied in clinics with shorter time, and the implementation and efficacy of the technique need to be further discussed. A case-control clinical trial is designed to compare the efficacy and safety of PTED with radiofrequency ablation in the treatment of LDH. Main outcome is Visual Analogue Scale for leg pain, secondary outcomes are Oswestry disability index, quality of life assessment, Burns Depression Checklist, recovery rate, complications, operation time and radiation exposure time, etc. The follow-up time points are 7 days, 1 month, 6 months and 12 months post-operation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 17, 2018
CompletedFirst Posted
Study publicly available on registry
August 16, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 26, 2018
CompletedAugust 16, 2018
August 1, 2018
2.7 years
July 17, 2018
August 14, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes on the Visual Analogue Scale for Leg Pain
Draw a line of 100 mm on the paper, the end of the horizontal line is 0, indicating no pain; The other end is 10, which is a very serious pain; The middle section shows varying degrees of pain. Let the patient draw a mark on the horizontal line to indicate the extent of the pain.
Baseline, 7 days, 1 month, 6 months and 12 months post-operation.
Secondary Outcomes (6)
Changes on the Oswestry Disability Index (ODI)
Baseline, 7 days, 1 month, 6 months and 12 months post-operation.
Changes on 36-Item Short-Form Quality of Life Questionnaire (SF-36)
Baseline, 7 days, 1 month, 6 months and 12 months post-operation.
Changes on Burns Depression Checklist
Baseline, 7 days, 1 month, 6 months and 12 months post-operation.
Changes on the Visual Analogue Scale for Back Pain
Baseline, 7 days, 1 month, 6 months and 12 months post-operation.
Complications
through study completion, up to 1year of follow-up.
- +1 more secondary outcomes
Study Arms (2)
PTED group
EXPERIMENTALPercutaneous transforaminal endoscopic discectomy (PTED). Use German Joimax company production of intervertebral foramen mirror operation system, the prone position, by preoperative X-ray locating the skin into the needle point, intervertebral level away from the spine line 8 \~ 10 cm, 18 g needle insertion, the Kambin security triangle directly through the middle of pathological changes of intervertebral disc. After the success of the puncture, remove the needle core, injection of contrast agent, methylene blue (9:1) mixture disk imaging, replace the godet, slight rotation step by step to insert the expansion sleeve, X-ray perspective to determine work under the correct position. Radiofrequency ablation is used to form nucleus pulposus and fibrous ring and stop bleeding.
RA group
ACTIVE COMPARATORRadiofrequency ablation (RA). Patients in prone position, local infiltration anesthesia, the puncture point for lesion clearance level, is apart from the spine line distance is 8 to 10 cm, in the perspective of the C-shaped arm X-ray machine; After the puncture needle was reached, the needle core was removed and the radiofrequency head was pierced through the puncture channel to the nucleus pulposus. In accordance with the method of melt into the shrinking exit, the intensity of the treatment by band 2, increased to 3 file again, according to the needle round mouth of 2, 4, 6, 8, 10, 12 o'clock to this process is repeated six times.
Interventions
The same as the descriptions in experimental group.
The same as the descriptions in active comparator group.
Eligibility Criteria
You may qualify if:
- Lumbar intervertebral disc herniation has been treated with conservative treatment of \> for 3 months, or can only temporarily improve symptoms to relieve pain, but can not be maintained for a long time, aged between 18 and 60;
- The symptoms and signs of lumbar intervertebral disc herniation are obviously consistent with those of CT or MRI;
- The protrusion size was \< 8.0mm, and imaging examination showed the protrusion of intervertebral disc, mild or moderate protrusion, without calcification, dissociation, and osseous spinal stenosis;
- Patients have a strong desire to treat, and understand radiofrequency thermal coagulation ablation and intervertebral endoscopic treatment of possible risk patients;
- Conservative treatment is ineffective and the surgical treatment is rejected.
You may not qualify if:
- Patients with spinal fractures, tumors and intervertebral discs have skin infections that affect the puncture;
- The combination of mental illness or cognitive dysfunction;
- Patients with serious diseases such as active tuberculosis or heart, lung, liver and kidney;
- Abnormal bleeding or coagulation function caused by various reasons;
- Menstrual period and lactation period;
- No informed consent is signed.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
FirstXianJiaotongU
Xi'an, Shaanxi, 710061, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yingang Zhang, MD
First Affiliated Hospital, Medical College of Xi'an Jiaotong University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessor do not know all the information about the data origin and the group.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 17, 2018
First Posted
August 16, 2018
Study Start
January 1, 2016
Primary Completion
September 1, 2018
Study Completion
September 26, 2018
Last Updated
August 16, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share